A Study of ONO-7018 in Patients With Relapsed or Refractory Non-Hodgkin Lymphoma

NCT06622226 · clinicaltrials.gov ↗

PHASE1

Phase

ACTIVE_NOT_RECRUITING

Status

24

Enrollment

INDUSTRY

Sponsor class

Conditions

Non Hodgkin Lymphoma

Interventions

DRUG: ONO-7018

Sponsor

Ono Pharmaceutical Co., Ltd.